Literature DB >> 32448809

Patterns of recurrence after laparoscopic versus open abdominal radical hysterectomy in patients with cervical cancer: a propensity-matched analysis.

Giorgio Bogani1, Fabio Ghezzi2, Luis Chiva3, Baldo Gisone4, Ciro Pinelli4, Andrea Dell'Acqua5, Jvan Casarin4, Antonino Ditto5, Francesco Raspagliesi6.   

Abstract

OBJECTIVE: Recent evidence has suggested that laparoscopic radical hysterectomy is associated with an increased risk of recurrence in comparison with open abdominal radical hysterectomy. The aim of our study was to identify patterns of recurrence after laparoscopic and open abdominal radical hysterectomy for cervical cancer.
METHODS: This a retrospective multi-institutional study evaluating patients with recurrent cervical cancer after laparoscopic and open abdominal surgery performed between January 1990 and December 2018. Inclusion criteria were: age ≥18 years old, radical hysterectomy (type B or type C), no recurrent disease, and clinical follow-up >30 days. The primary endpoint was to evaluate patterns of first recurrence following laparoscopic and open abdominal radical hysterectomy. The secondary endpoint was to estimate the effect of the primary surgical approach (laparoscopy and open surgery) in post-recurrence survival outcomes (event-free survival and overall survival). In order to reduce possible confounding factors, we applied a propensity-matching algorithm. Survival outcomes were estimated using the Kaplan-Meier model.
RESULTS: A total of 1058 patients were included in the analysis (823 underwent open abdominal radical hysterectomy and 235 patients underwent laparoscopic radical hysterectomy). The study included 117 (14.2%) and 35 (14.9%) patients who developed recurrent cervical cancer after open or laparoscopic surgery, respectively. Applying a propensity matched comparison (1:2), we reduced the population to 105 patients (35 vs 70 patients with recurrence after laparoscopic and open radical hysterectomy). Median follow-up time was 39.1 (range 4-221) months and 32.3 (range 4-124) months for patients undergoing open and laparoscopic surgery, respectively. Patients undergoing laparoscopic radical hysterectomy had shorter progression-free survival than patients undergoing open abdominal surgery (HR 1.98, 95% CI 1.32 to 2.97; p=0.005). Patients undergoing laparoscopic radical hysterectomy were more likely to develop intrapelvic recurrences (74% vs 34%; p<0.001) and peritoneal carcinomatosis (17% vs 1%; p=0.005) than patients undergoing open surgery.
CONCLUSIONS: Patients undergoing laparoscopic radical hysterectomy are at higher risk of developing intrapelvic recurrences and peritoneal carcinomatosis. Further evidence is needed in order to corroborate our findings. © IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cervical cancer; laparoscopes; neoplasm recurrence, local

Year:  2020        PMID: 32448809     DOI: 10.1136/ijgc-2020-001381

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  8 in total

Review 1.  Fertility-Sparing Treatment for Early-Stage Cervical Cancer ≥ 2 cm: A Problem with a Thousand Nuances-A Systematic Review of Oncological Outcomes.

Authors:  Carlo Ronsini; Maria Cristina Solazzo; Nicolò Bizzarri; Domenico Ambrosio; Marco La Verde; Marco Torella; Raffaela Maria Carotenuto; Luigi Cobellis; Nicola Colacurci; Pasquale De Franciscis
Journal:  Ann Surg Oncol       Date:  2022-09-05       Impact factor: 4.339

Review 2.  Protective operative techniques in radical hysterectomy in early cervical carcinoma and their influence on disease-free and overall survival: a systematic review and meta-analysis of risk groups.

Authors:  Johanna Kampers; E Gerhardt; P Sibbertsen; T Flock; R Klapdor; H Hertel; M Jentschke; P Hillemanns
Journal:  Arch Gynecol Obstet       Date:  2021-05-22       Impact factor: 2.344

3.  Efficacy evaluation of vaginal-assisted laparoscopic radical hysterectomy and laparoscopic radical hysterectomy for cervical cancer: a single-center retrospective case series study.

Authors:  Huimin Wang; Dianzhen Li; Chunyan Wang; Xiaobin Wang; Mingxin Yu; Xin Zhang; Liankun Li; Qingdong Zeng; Zaiqiu Long; Wei Zheng; Guangcong Liu; Danbo Wang
Journal:  Ann Transl Med       Date:  2022-01

Review 4.  Perioperative morbidity of different operative approaches in early cervical carcinoma: a systematic review and meta-analysis comparing minimally invasive versus open radical hysterectomy.

Authors:  J Kampers; E Gerhardt; P Sibbertsen; T Flock; H Hertel; R Klapdor; M Jentschke; P Hillemanns
Journal:  Arch Gynecol Obstet       Date:  2021-10-08       Impact factor: 2.493

5.  The Role of Conization before Radical Hysterectomy in Cervical Cancer including High Risk Factors of Recurrence: Propensity Score Matching.

Authors:  Chi-Son Chang; Ji Song Min; Ki Hyeon Song; Chel Hun Choi; Tae-Joong Kim; Jeong-Won Lee; Byoung-Gie Kim; Yoo-Young Lee
Journal:  Cancers (Basel)       Date:  2022-08-10       Impact factor: 6.575

Review 6.  Radical Hysterectomy for Early Stage Cervical Cancer.

Authors:  Giorgio Bogani; Violante Di Donato; Giovanni Scambia; Francesco Raspagliesi; Vito Chiantera; Giulio Sozzi; Tullio Golia D'Augè; Ludovico Muzii; Pierluigi Benedetti Panici; Ottavia D'Oria; Enrico Vizza; Andrea Giannini
Journal:  Int J Environ Res Public Health       Date:  2022-09-15       Impact factor: 4.614

7.  Surgery followed by concurrent radiochemotherapy as treatment for patients with locally recurrent cervical cancer.

Authors:  Xiang Zhang; Zhongbo Chen; Jianhong Chen; Junjian Wang; Yingchang Wang; Jianqing Zhu
Journal:  Transl Cancer Res       Date:  2021-10       Impact factor: 1.241

Review 8.  A meta-analysis of survival after minimally invasive radical hysterectomy versus abdominal radical hysterectomy in cervical cancer: center-associated factors matter.

Authors:  Si Sun; Jing Cai; Ruixie Li; Yujia Wang; Jing Zhao; Yuhui Huang; Linjuan Xu; Qiang Yang; Zehua Wang
Journal:  Arch Gynecol Obstet       Date:  2022-01-21       Impact factor: 2.493

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.